208750 | InSolution™ ALLN - CAS 110044-82-1 - Calbiochem

208750
Price could not be retrieved
Minimum Quantity needs to be mulitiple of
Upon Order Completion More Information
You Saved ()
 
Request Pricing
Limited AvailabilityLimited Availability
Stocked 
Discontinued
Limited Quantities Available
Available
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      View Pricing & Availability
      Click To Print This Page

      Overview

      Replacement Information

      Key Specifications Table

      Empirical FormulaCAS #
      C₂₀H₃₇N₃O₄ 110044-82-1

      Pricing & Availability

      Catalog NumberAvailability Packaging Qty/Pack Price Quantity
      208750-5MG
      Retrieving availability...
      Limited AvailabilityLimited Availability
      Stocked 
      Discontinued
      Limited Quantities Available
      Available
        Remaining : Will advise
          Remaining : Will advise
          Will advise
          Contact Customer Service

          Glass bottle 5 mg
          Retrieving price...
          Price could not be retrieved
          Minimum Quantity needs to be mulitiple of
          Upon Order Completion More Information
          You Saved ()
           
          Request Pricing
          Description
          Catalogue Number208750
          Brand Family Calbiochem®
          SynonymsCalpain Inhibitor I, LLNL, MG 101, Proteasome Inhibitor V
          References
          ReferencesMilligan, S.A., et al. 1996. Arch. Biochem. Biophys. 335, 388.
          Griscavage, J.M., et al. 1995. Biochem. Biophys. Res. Commun. 215, 721.
          Squier, M.K., et al. 1994. J. Cell Physiol. 159, 229.
          Rami, J., and Kreiglstein, J. 1993. Brain Res. 609, 67.
          Product Information
          CAS number110044-82-1
          ATP CompetitiveN
          FormClear colorless solution
          FormulationA 10 mM (5 mg/1.30 ml) solution of ALLN (Cat. No. 208719) in DMSO.
          Hill FormulaC₂₀H₃₇N₃O₄
          Chemical formulaC₂₀H₃₇N₃O₄
          ReversibleN
          Structure formula ImageStructure formula Image
          Applications
          Biological Information
          Primary Targetcalpain 1
          Primary Target K<sub>i</sub>190 nM, 220 nM, 150 nM, 500 pM, against calpain I, calpain II, cathepsin B, and cathepsin L, respectively
          Purity≥95% by HPLC
          Physicochemical Information
          Cell permeableY
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          Safety Information
          R PhraseR: 36/38

          Irritating to eyes and skin.
          S PhraseS: 26

          In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Blue Ice Only
          Toxicity Flammable
          Storage -20°C
          Protect from Light Protect from light
          Do not freeze Ok to freeze
          Special InstructionsFollowing initial thaw, aliquot and freeze (-20°C).
          Packaging Information
          Packaged under inert gas Packaged under inert gas
          Transport Information
          Supplemental Information
          Specifications

          Documentation

          SDS

          Title

          Safety Data Sheet (SDS) 

          Certificates of Analysis

          TitleLot Number
          208750

          References

          Reference overview
          Milligan, S.A., et al. 1996. Arch. Biochem. Biophys. 335, 388.
          Griscavage, J.M., et al. 1995. Biochem. Biophys. Res. Commun. 215, 721.
          Squier, M.K., et al. 1994. J. Cell Physiol. 159, 229.
          Rami, J., and Kreiglstein, J. 1993. Brain Res. 609, 67.

          Citations

          Title
        • Ping Han, et al. (2005) Suppression of Cyclin-Dependent Kinase 5 Activation by Amyloid Precursor Protein: A Novel Excitoprotective Mechanism Involving Modulation of Tau Phosphorylation. Journal of Neuroscience 25, 11542-11552.
        • Data Sheet

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision28-May-2008 RFH
          SynonymsCalpain Inhibitor I, LLNL, MG 101, Proteasome Inhibitor V
          DescriptionA 10 mM solution of ALLN (Cat. No. 208719) in anhydrous DMSO. Inhibitor of calpain I (Ki = 190 nM), calpain II (Ki = 220 nM), cathepsin B (Ki = 150 nM), and cathepsin L (Ki = 0.5 nM). Inhibits neutral cysteine proteases and proteasome (Ki = 6 µM). Protects against neuronal damage caused by hypoxia and ischemia. Inhibits apoptosis in thymocytes and metamyelocytes. Inhibits cell cycle progression at the G1/S border and metaphase/anaphase in CHO cells by inhibiting cyclin B degradation. Also prevents nitric oxide production by activated macrophages by interfering with transcription of the inducible nitric oxide synthase gene. Inhibits the proteolysis of IkB-α and IkB-β by the ubiquitin-proteasome complex.
          FormClear colorless solution
          FormulationA 10 mM (5 mg/1.30 ml) solution of ALLN (Cat. No. 208719) in DMSO.
          Intert gas (Yes/No) Packaged under inert gas
          CAS number110044-82-1
          Chemical formulaC₂₀H₃₇N₃O₄
          Structure formulaStructure formula
          Purity≥95% by HPLC
          Storage -20°C
          Protect from light
          Do Not Freeze Ok to freeze
          Special InstructionsFollowing initial thaw, aliquot and freeze (-20°C).
          Toxicity Flammable
          ReferencesMilligan, S.A., et al. 1996. Arch. Biochem. Biophys. 335, 388.
          Griscavage, J.M., et al. 1995. Biochem. Biophys. Res. Commun. 215, 721.
          Squier, M.K., et al. 1994. J. Cell Physiol. 159, 229.
          Rami, J., and Kreiglstein, J. 1993. Brain Res. 609, 67.
          Citation
        • Ping Han, et al. (2005) Suppression of Cyclin-Dependent Kinase 5 Activation by Amyloid Precursor Protein: A Novel Excitoprotective Mechanism Involving Modulation of Tau Phosphorylation. Journal of Neuroscience 25, 11542-11552.